Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials (Q39831894)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

0 references

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Jolie Ringash

4

0 references

Jurgen Vercauteren

object named as

Jurgen Vercauteren

8

0 references

Andrew Bottomley

19

object named as

Andrew Bottomley

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Charles S Cleeland

9

object named as

Charles S Cleeland

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

11

object named as

Carolyn Gotay

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

John T Maringwa

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Chantal Quinten

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Madeleine King

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

David Osoba

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Corneel Coens

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Francesca Martinelli

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Henning Flechtner

10

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Eva Greimel

12

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Martin J Taphoorn

13

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Bryce B Reeve

14

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Joseph Schmucker-Von Koch

15

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Joachim Weis

16

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Egbert F Smit

17

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Jan P van Meerbeeck

18

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

EORTC PROBE project and the Lung Cancer Group

20

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1753-1760

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Methods to explain the clinical significance of health status measures

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Commentary--goodbye M(C)ID! Hello MID, where do you come from?

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ).

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-G.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Interpretation of quality of life changes

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Defining clinically meaningful change in health-related quality of life.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Half standard deviation estimate of the minimally important difference in HRQOL scores?

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Optimistic biases about personal risks

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Interpreting clinically significant changes in patient-reported outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Interpreting differences in quality of life: The FACT-H&N in laryngeal cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1016-5

21 January 2018

Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/20886240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales

1 reference

https://pubmed.ncbi.nlm.nih.gov/20886240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simple as possible? Or too simple? Possible limits to the universality of the one half standard deviation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20886240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20886240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20886240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20886240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-010-1016-5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39831894&oldid=2203204183"